https://www.selleckchem.com/pr....oducts/hsp27-inhibit
7%, cases with brain metastasis 20%, cases with pleural effusion 20.8%, and histopathological evaluation (well-differentiated 21.42%, moderately-differentiated 13.79%, poorly-differentiated 36.11%, and adenosquamous disease 40.9%). Genetic mutation studies revealed PD-L1 positivity in 18.1% cases with EGFR mutation, 50% of ALK-IHC positive cases, and 33.3% ALK-FISH positive cases. No or very weak correlation (r less then 0.3) in PD-L1 expression with gene mutations or clinicopathological parameters was observed. Conclusions T
Like
Comment
Share
